Scientists Show How Bone-Bordering Cells May Help Shape a Skull
Mount Sinai study of mice searched for the cells and genes that may orchestrate how skull bones are joined together
A skull is not one single bone but rather a collection of bone plates joined together early in development. In a study of mice, scientists at the Icahn School of Medicine at Mount Sinai showed how the activity of one gene, turned on in a newly discovered group of bone-bordering cells, may play an important role in shaping the skull. The skulls of mice that were missing the gene were misshapen and were depleted of the cells in a manner that is reminiscent of craniosynostosis, a developmental disorder that affects about one out every 2,500 babies born in the United States.
The lead author of the study was Greg Holmes, PhD, Assistant Professor of Genetics and Genomic Sciences at Icahn Mount Sinai.
The study focused on the cells of the coronal suture, a fibrous joint that connects the front and middle bone plates. In humans, it runs across the top of the skull, from one temple to the other. Throughout development, the suture is filled with a buffering tissue called mesenchyme, which contains stem cells. The stem cells provide a constant source of new bone cells, or osteoblasts, which are needed as the plates on either side grow and the skull expands. In adults, these stem cells are depleted and the joints between the bone plates fuse.
Craniosynostosis is a birth defect in which this fusion happens prematurely, resulting in babies born with misshapen skulls who may develop neurological problems. Scientists have shown that about 25 percent of cases are linked to genetic mutations and that normal suture development is controlled by a variety of growth factors. Of all the sutures needed to form a skull, the coronal suture is commonly affected in craniosynostosis.
In this study, the Holmes lab worked with researchers in the labs of Bin Zhang, PhD, Harm van Bakel, PhD, and Ethylin Wang Jabs, MD, of Icahn Mount Sinai. Together they studied how the genetic activity in the cells of the coronal suture changes during early development. To do this, they measured the RNA levels of individual suture cells from embryonic mice about one to three days before the mice were normally born.
Their results suggested that a gene encoding a molecule called hedgehog interacting protein (HHIP) plays a unique and critical role in coronal suture development. The gene was more active in a novel group of mesenchyme cells than it was in osteoblasts. In fact, the scientists saw the opposite trend when they looked at the cells of other sutures. Tracing experiments suggested that after birth the coronal suture osteoblasts were derived from these mesenchyme cells. Moreover, the skulls of embryonic mutant mice that were missing the HHIP gene were shaped differently than those from normal mice. Specifically, there were fewer mesenchymal cells separating the skull bones and the mutant coronal suture was close to fusing.
Hedgehog proteins are growth factors known to guide normal growth and development in a variety of species, including the promotion of bone growth. HHIP is known to inhibit hedgehog activity. To the authors of this study, their results suggest that the HHIP gene reduced hedgehog activity to allow normal development of the coronal suture. They hope that advanced single-cell genetic studies like this one will give researchers a more thorough understanding of how a skull is shaped under healthy and disease conditions.
Who: Greg Holmes, PhD, Assistant Professor of Genetics and Genomic Sciences at Icahn Mount Sinai.
This study was support by the National Institutes of Health (DE024448, DE026814, DE027677, HD078233, and DE030596) and the Scientific Computing group at the Icahn Mount Sinai.
Article
Holmes, G. et al., Single-cell analysis identifies a key role for Hhip in murine coronal suture development. Nature Communications, December 8, 2021, DOI: 10.1038/s41467-021-27402-5
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases
World’s First Cannabis Chromosome Map Reveals the Plant’s Evolutionary History
Dec 03, 2018 View All Press Releases